|
Anti-STEAP1 CAR T-cells Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Anti-STEAP1 CAR T Cells, Anti-STEAP1 CAR-T Cells, STEAP1 CAR-T Cells, STEAP1-targeting CAR T-cells
Seattle, Washington1 trial
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Fred Hutch/University of Washington Cancer Consortium
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.